journal article·2022-08

Tongue cancer tailored photosensitizers for NIR-II fluorescence imaging guided precise treatment

Baoli Yin, Qiaoqiao Qin, Zhe Li, Youjuan Wang, Xinlin Liu, Yongchao Liu, Shuangyan Huan, Xiaobing Zhang, Guosheng Song

Nano Today· Volume 45
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (55)

Show source-provided references
1. World Workshop on Oral Medicine VII: Targeting the oral microbiome Part 2: Current knowledge on malignant and potentially malignant oral disorders
2. Molybdenum diphosphide nanorods with laser-potentiated peroxidase catalytic/mild-photothermal therapy of oral cancer
3. Cancer statistics, 202010.3322/caac.21590 ↗
4. Mesenchymal stem cells functionalized sonodynamic treatment for improving therapeutic efficacy and compliance of orthotopic oral cancer10.1002/adma.202005295 ↗
5. Oral cancer: a historical review10.3390/ijerph17093168 ↗
6. Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review10.1016/j.ejca.2017.05.026 ↗
7. Cervical lymph node metastasis from early-stage squamous cell carcinoma of the oral tongue
8. MG53 inhibits the progression of tongue cancer cells through regulating PI3K-AKT signaling pathway: evidence from 3D cell culture and animal model10.1002/smll.201805492 ↗
9. Engineered protein photo-thermal hydrogels for outstanding in situ tongue cancer therapy10.1002/adma.202100619 ↗
10. Nanoparticle delivery of Wnt-1 siRNA enhances photodynamic therapy by inhibiting epithelial–mesenchymal transition for oral cancer10.1039/C6BM00833J ↗
11. De Vincentiis, M.; Tombolini, V., Treatment improvement and better patient care: which is the most important one in oral cavity cancer?10.1186/s13014-014-0263-x ↗
12. Oral cancer: current role of radiotherapy and chemotherapy10.4317/medoral.18772 ↗
13. Reactive oxygen species-responsive nanoparticles based on PEGlated prodrug for targeted treatment of oral tongue squamous cell carcinoma by combining photodynamic therapy and chemotherapy10.1021/acsami.8b08269 ↗
14. Overcoming the Achilles’ heel of photodynamic therapy10.1039/C6CS00616G ↗
15. Two-photon excitation nanoparticles for photodynamic therapy10.1039/C6CS00442C ↗
16. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
17. Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer10.1002/EXP.20210003 ↗
18. The role of porphyrin chemistry in tumor imaging and photodynamic therapy10.1039/B915149B ↗
19. Glycosylated porphyrins, phthalocyanines, and other porphyrinoids for diagnostics and therapeutics10.1021/acs.chemrev.5b00244 ↗
20. Metal-free nanoassemblies of water-soluble photosensitizer and adenosine triphosphate for efficient and precise photodynamic cancer therapy10.1021/acsnano.0c09913 ↗
21. Rose-bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies10.1016/j.biomaterials.2013.11.066 ↗
22. A thermally activated delayed fluorescence photosensitizer for photodynamic therapy of oral squamous cell carcinoma under low laser intensity10.1039/D1TB00719J ↗
23. Nanobody modified high-performance AIE photosensitizer nanoparticles for precise photodynamic oral cancer therapy of patient-derived tumor xenograft10.1016/j.biomaterials.2021.120870 ↗
24. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
25. Modulating hypoxia via nanomaterials chemistry for efficient treatment of solid tumors10.1021/acs.accounts.8b00214 ↗
26. Intelligent MnO2 nanosheets anchored with upconversion nanoprobes for concurrent pH-/H2O2-responsive UCL imaging and oxygen-elevated synergetic therapy10.1002/adma.201405141 ↗
27. Perfluorocarbon-loaded hollow Bi2Se3 nanoparticles for timely supply of oxygen under near-infrared light to enhance the radiotherapy of cancer10.1002/adma.201504617 ↗
28. Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies10.1039/D0CS01370F ↗
29. Type I photodynamic therapy by organic–inorganic hybrid materials: from strategies to applications10.1016/j.ccr.2019.05.016 ↗
30. BODIPY-based photodynamic agents for exclusively generating superoxide radical over singlet oxygen10.1002/anie.202106748 ↗
31. Strategy of fabricating type I photosensitizer for photodynamic therapy in cancer cells and pathogens10.1021/acsnano.1c01577 ↗
32. Utilization of nonradiative excited-state dissipation for promoted phototheranostics based on an AIE-active type I ROS generator10.1021/acsami.1c19008 ↗
33. Electron-acceptor density adjustments for preparation conjugated polymers with NIR-II absorption and brighter NIR-II fluorescence and 1064 nm active photothermal/gas therapy10.1016/j.biomaterials.2021.121319 ↗
34. An NIR-II-emissive photosensitizer for hypoxia-tolerant photodynamic theranostics10.1002/adma.202003471 ↗
35. Achieving high-performance photothermal and photodynamic effects upon combining D–A structure and nonplanar conformation10.1002/smll.202000909 ↗
36. Mitochondria-targeted polydopamine nanocomposite with AIE photosensitizer for image-guided photodynamic and photothermal tumor ablation10.1002/smll.201902352 ↗
37. Time-dependent photodynamic therapy for multiple targets: a highly efficient AIE-active photosensitizer for selective bacterial elimination and cancer cell ablation10.1002/anie.201909706 ↗
38. Fine-tuning the electronic structure of heavy-atom-free BODIPY photosensitizers for fluorescence imaging and mitochondria-targeted photodynamic therapy10.1039/D0SC01171A ↗
39. Heavy-atom-free photosensitizers: from molecular design to applications in the photodynamic therapy of cancer10.1021/acs.accounts.0c00606 ↗
40. Near-infrared-II light excitation thermosensitive liposomes for photoacoustic imaging-guided enhanced photothermal-chemo synergistic tumor therapy10.1039/D1BM01669E ↗
41. Zhu · Dosim. Photo Photodyn. · 2006 · 3 · 23410.1016/j.pdpdt.2006.08.002 ↗
42. Photodynamic therapy combined with immunotherapy for an advanced esophageal cancer with an obstruction post metal stent implantation: a case report and literature review
43. Lowering photosensitizer doses and increasing fluences induce apoptosis in tumor bearing mice10.1364/BOE.7.002641 ↗
44. Single 808 nm NIR light-induced imaging-guided multifunctional cancer therapy platform10.1002/adfm.201500464 ↗
45. Conjugated-polyelectrolyte-based polyprodrug: targeted and image-guided photodynamic and chemotherapy with on-demand drug release upon irradiation with a single light source10.1002/anie.201402189 ↗
46. Multifunctional organic nanoparticles with aggregation-induced emission (AIE) characteristics for targeted photodynamic therapy and RNA interference therapy10.1039/C5CC07818K ↗
47. Near-infrared-II molecular dyes for cancer imaging and surgery10.1002/adma.201900321 ↗
48. Activatable fluorescence sensors for in vivo bio-detection in the second near-infrared window10.1039/D0SC04789A ↗
49. Rational design of conjugated small molecules for superior photothermal theranostics in the NIR-II biowindow10.1002/adma.202001146 ↗
50. Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer10.1038/s41467-021-21047-0 ↗
51. An acceptor–donor–acceptor structured small molecule for effective NIR triggered dual phototherapy of cancer10.1002/adfm.201910301 ↗
52. Type I photosensitizers based on phosphindole oxide for photodynamic therapy: apoptosis and autophagy induced by endoplasmic reticulum stress10.1039/D0SC00785D ↗
53. Oxygen-embedded quinoidal acene based semiconducting chromophore nanoprobe for amplified photoacoustic imaging and photothermal therapy10.1021/acs.analchem.9b04429 ↗
54. Classification of tongue cancer resection and treatment algorithm10.1002/jso.24991 ↗
55. Risk factors for osteonecrosis of the jaw in oral cancer patients after surgery and eventual adjuvant treatment: the potential role of chemotherapy10.1016/j.radonc.2017.05.001 ↗